Loading clinical trials...
Loading clinical trials...
177Lu Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Nonprostate Metastatic Solid Tumors: A Pilot Study
Conditions
Interventions
177Lu-J591
Locations
1
United States
Weill Cornell Medical College
New York, New York, United States
Start Date
July 1, 2009
Primary Completion Date
June 1, 2018
Completion Date
December 31, 2021
Last Updated
February 2, 2022
NCT05468034
NCT04541381
NCT03137095
NCT07547774
NCT04852887
NCT06393374
Lead Sponsor
Weill Medical College of Cornell University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions